Serum trace elements, anthropometric data, and oxidative stress markers are often altered in patients diagnosed with Alzheimer's disease (AD) or other types of dementia (OTD). However, these parameters are rarely examined together before disease onset in a single study population.
Objective
This nested case-control study aims to investigate anthropometric data, serum trace elements, exchangeable copper (CuEXC), and oxidative stress markers to identify early associations with the risk of AD or OTD.
Methods
From the European Prospective Investigation into Cancer and Nutrition-Potsdam cohort (DRKS-ID: DRKS00020593), the High Fat Diet, Microbiota, and Neuroinflammation in the Progression of Alzheimer study was generated. One hundred twenty-eight individuals who developed AD or OTD were identified, approximately 15.7 years after baseline data collection, and matched for age, sex, fasting status, and season of blood sampling with 512 controls. Serum levels of manganese (Mn), iron (Fe), copper (Cu), zinc (Zn), selenium (Se), iodine (I), CuEXC, and plasma malondialdehyde (MDA) and 3-nitrotyrosine (3-NT) were analyzed.
Results
Cases and non-cases did not differ in anthropometric data or oxidative stress markers. Female cases exhibited a trend of elevated serum Cu and CuEXC levels compared to female non-cases. A higher Se/Cu ratio suggested an inverse association (OR = 0.72, 95% CI: 0.56–0.92), while an increased Cu/Zn ratio was positively associated (OR = 2.1, 95% CI: 1.1–4.1) with AD or OTD incidence.
Conclusions
Ratios of serum trace elements, rather than individual levels, show early associations with the risk of AD or OTD while anthropometric and oxidative stress markers did not.
PrinceMWimoAGuerchetM, et al.World Alzheimer report 2015. The global impact of dementia: An analysis of prevalence, incidence, cost and trends. London, UK: Alzheimer's Disease International, 2015.
2.
RavagliaGFortiPLucicesareA, et al.Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology2008; 70: 1786–1794.
3.
TanZSSpartanoNLBeiserAS, et al.Physical activity, brain volume, and dementia risk: the Framingham study. J Gerontol A Biol Sci Med Sci2017; 72: 789–795.
4.
De BruijnRFAGSchrijversEMCDe GrootKA, et al.The association between physical activity and dementia in an elderly population: the Rotterdam study. Eur J Epidemiol2013; 28: 277–283.
5.
Tort-ColetNSánchez-BenavidesGMinguillonC, et al.Association of waist-to-hip ratio with Alzheimer’s disease and neuroinflammation biomarkers in cognitively unimpaired adults. Alzheimers Dement2023; 19: e076415.
6.
LiuZYangHChenS, et al.The association between body mass index, waist circumference, waist-hip ratio and cognitive disorder in older adults. J Public Health (Oxf)2019; 41: 305–312.
7.
HamerMBattyGD. Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study. Neurology2019; 92: e594–e600.
8.
QuYHuHYOuYN, et al.Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev2020; 115: 189–198.
9.
LiJJoshiPFangT, et al.Mid-to late-life body mass index and dementia risk: 38 years of follow-up of the Framingham study. Am J Epidemiol2021; 190: 2503–2510.
10.
BaudryJKoppJFBoeingH, et al.Changes of trace element status during aging: results of the EPIC-Potsdam cohort study. Eur J Nutr2020; 59: 3045–3058.
11.
Mendoza-NúñezVMRuiz-RamosMSánchez-RodríguezMA, et al.Aging-related oxidative stress in healthy humans. Tohoku J Exp Med2007; 213: 261–268.
12.
PagliaGMiedicoOCristofanoA, et al.Distinctive pattern of serum elements during the progression of Alzheimer’s disease. Sci Rep2016; 6: 22769.
13.
RoyRGMandalPKMaroonJC. Oxidative stress occurs prior to amyloid Aβ plaque formation and tau phosphorylation in Alzheimer’s disease: role of glutathione and metal ions. ACS Chem Neurosci2023; 14: 2944–2954.
14.
PadurariuMCiobicaAHritcuL, et al.Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett2010; 469: 6–10.
15.
LiYDuYZhouY, et al.Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death. Cell Commun Signal2023; 21: 327.
16.
LeiPScottABushAI. The essential elements of Alzheimer’s disease. J Biol Chem2021; 296: 100105.
17.
HaneFTranGAttwoodSJ, et al.Cu2+ affects amyloid-β (1–42) aggregation by increasing peptide-peptide binding forces. PLoS One2013; 8: e59005.
18.
BoeingHKorfmannABergmannMM. Recruitment procedures of EPIC-Germany. Ann Nutr Metab1999; 43: 205–215.
19.
BergmannMMBussasUBoeingH. Follow-up procedures in EPIC-Germany–data quality aspects. European prospective investigation into cancer and nutrition. Ann Nutr Metab1999; 43: 225–234.
20.
KoppJFMüllerSMPohlG, et al.A quick and simple method for the determination of six trace elements in mammalian serum samples using ICP-MS/MS. J Trace Elem Med Biol2019; 54: 221–225.
21.
Rodríguez-GonzálezPMarchante-GayónJMGarcía AlonsoJI, et al.Isotope dilution analysis for elemental speciation: a tutorial review. Spectrochim Acta Part B At Spectrosc2005; 60: 151–207.
22.
TuchtenhagenMStibollerMWittB, et al.A novel approach for the determination of exchangeable copper in serum using protein precipitation. J Anal At Spectrom2023; 38: 587–594.
23.
WongSHYKnightJAHopferSM, et al.Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem1987; 33: 214–220.
24.
WeberDStuetzWBernhardW, et al.Oxidative stress markers and micronutrients in maternal and cord blood in relation to neonatal outcome. Eur J Clin Nutr2014; 68: 215–222.
25.
WeberDKneschkeNGrimmS, et al.Rapid and sensitive determination of protein-nitrotyrosine by ELISA: application to human plasma. Free Radic Res2012; 46: 276–285.
26.
SchienkiewitzASchulzeMBHoffmannK, et al.Body mass index history and risk of type 2 diabetes: results from the European prospective investigation into cancer and nutrition (EPIC)–Potsdam study. Am J Clin Nutr2006; 84: 427–433.
27.
BoeingHWahrendorfJBeckerN. EPIC-Germany–A source for studies into diet and risk of chronic diseases. European investigation into cancer and nutrition. Ann Nutr Metab1999; 43: 195–204.
28.
Klipstein-GrobuschKBeckerNKrokeA, et al.Patterns of past alcohol consumption in the EPIC-Germany cohorts. European investigation into cancer and nutrition. Ann Nutr Metab1999; 43: 258–265.
29.
LubinJHColtJSCamannD, et al.Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect2004; 112: 1691.
30.
ShangSZhangBWangJ, et al.The relationship between waist-to-hip ratio, BMI index and cognitive impairment in those aged 40 years or above: a cross-sectional study in a rural area of Xi’an, China. Alzheimers Dement2020; 16: e043885.
31.
LiDDZhangWWangZY, et al.Serum copper, zinc, and iron levels in patients with Alzheimer’s disease: a meta-analysis of case-control studies. Front Aging Neurosci2017; 9: 261619.
32.
TyczyńskaMGędekMBrachetA, et al.Trace elements in Alzheimer’s disease and dementia: the current state of knowledge. J Clin Med2024; 13: 2381.
33.
MehtaSWEikumR. Effect of estrogen on serum and tissue levels of copper and zinc. Adv Exp Med Biol1989; 258: 155–162.
34.
O’NealMA. Women and the risk of Alzheimer’s disease. Front Glob Womens Health2023; 4: 1324522.
35.
NascimentoCQDBarros-NetoJAVieiraNFL, et al.Selenium concentrations in elderly people with Alzheimer's disease: a cross-sectional study with control group. Rev Bras Enferm2021; 74(Suppl 2): e20200984.
36.
CardosoBROngTPJacob-FilhoW, et al.Nutritional status of selenium in Alzheimer's disease patients. Br J Nutr2010; 103: 803–806.
37.
SochaKKlimiukKNaliwajkoSK, et al.Dietary habits, selenium, copper, zinc and total antioxidant status in serum in relation to cognitive functions of patients with Alzheimer’s disease. Nutrients2021; 13: 287.
38.
TashakoriMJamalizadehANejad-GhaderiM, et al.Association between the copper/selenium ratio and the immune response to SARS-CoV-2 infection. Biomark Med2023; 17: 307–317.
39.
MittagJSchomburgL. Der selen/Kupfer Koeffizient-ein neuer biomarker für Schilddrüsenhormonresistenz?Perspect Sci (Neth)2015; 3: 44–45.
40.
González-DomínguezRGarcía-BarreraTGómez-ArizaJL. Homeostasis of metals in the progression of Alzheimer’s disease. Biometals2014; 27: 539–549.
41.
MravunacMSzymlek-GayEADalyRM, et al.Greater circulating copper concentrations and copper/zinc ratios are associated with lower psychological distress, but not cognitive performance, in a sample of Australian older adults. Nutrients2019; 11: 2503.
42.
SinghISagareAPComaM, et al.Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A2013; 110: 14771–14776.
43.
PellowskiDEbertFBornhorstJ, et al.Zinc-modulated bidirectional copper transfer across the blood-brain barrier in a porcine brain capillary endothelial cell culture model system. J Trace Elem Med Biol2024; 86: 127547.
44.
DuKLiuMPanY, et al.Association of serum manganese levels with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Nutrients2017; 9: 231.
45.
BotchwayBOALiuXZhouY, et al.Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine. J Transl Med2023; 21: 351.
46.
NieYChuCQinQ, et al.Lipid metabolism and oxidative stress in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Brain Pathol2024; 34: e13202.
47.
ButterfieldDAReedTTPerluigiM, et al.Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer’s disease. Brain Res2007; 1148: 243.
48.
LópezNTormoCDe BlasI, et al.Oxidative stress in Alzheimer’s disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis2013; 33: 823–829.
49.
RaniPKrishnanSCathrineCR. Study on analysis of peripheral biomarkers for Alzheimer’s disease diagnosis. Front Neurol2017; 8: 263010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
